Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3-biphenylylacetic Acid
2. 4-biphenylylacetic Acid
3. Biphenylacetic Acid
4. Biphenylylacetic Acid
5. Biphenylylacetic Acid, 14c-labeled
6. Traxam
1. 4-biphenylacetic Acid
2. 5728-52-9
3. 4-biphenylylacetic Acid
4. Traxam
5. Dolinac
6. Biphenyl-4-ylacetic Acid
7. Napageln
8. 4-carboxymethylbiphenyl
9. 2-(4-phenylphenyl)acetic Acid
10. P-biphenylylacetic Acid
11. [1,1'-biphenyl]-4-acetic Acid
12. P-biphenylacetic Acid
13. Seltouch
14. Biphenyl-4-acetic Acid
15. Ljc 10,141
16. Biphenyl-4-yl-acetic Acid
17. 4-biphenylaceticacid
18. Acetic Acid, (4-biphenylyl)-
19. Cl 83544
20. Ly 61017
21. (1,1'-biphenyl)-4-acetic Acid
22. L-141
23. Nsc 16284
24. 2-(biphenyl-4-yl)acetic Acid
25. 2-([1,1'-biphenyl]-4-yl)acetic Acid
26. 4-biphenyl Acetic Acid
27. Ljc-10141
28. Nsc-16284
29. Cl-83544
30. Cl 83,544
31. Mls000069466
32. 94wnj5u8l7
33. Chebi:31597
34. [1,1'-biphenyl]-4-ylacetic Acid
35. Ly-61017
36. Ncgc00016660-01
37. Smr000059071
38. Cas-5728-52-9
39. Dsstox_cid_25389
40. Dsstox_rid_80846
41. Dsstox_gsid_45389
42. Felbinacum [latin]
43. Felbinaco [spanish]
44. Felbinacum
45. Felbinaco
46. 2-{[1,1'-biphenyl]-4-yl}acetic Acid
47. Felbinac [usan:inn:ban:jan]
48. Einecs 227-233-2
49. Mfcd00004351
50. Brn 1211592
51. Unii-94wnj5u8l7
52. Dolonac
53. Flexfree
54. Ledergel
55. Napagel
56. Selspot
57. Sumilu
58. L 141
59. Zenol Exum
60. Felbinac (tn)
61. Bp4
62. Dolinac (tn)
63. Bpaa
64. Emec
65. Biphenyl-4acetic Acid
66. 4-biphenyl-acetic Acid
67. Felbinac [usan]
68. Opera_id_534
69. Felbinac [inn]
70. Felbinac [jan]
71. Felbinac [mi]
72. 4-biphenylyl Acetic Acid
73. 4-phenylphenylacetic Acid
74. Prestwick0_000893
75. Prestwick1_000893
76. Prestwick2_000893
77. Prestwick3_000893
78. (4'-biphenyl)acetic Acid
79. Felbinac [who-dd]
80. (biphenyl-4-yl)acetic Aci
81. (biphenyl-4-yl)acetic Acid
82. Oprea1_058748
83. Schembl26084
84. Bspbio_000706
85. 4-biphenylacetic Acid, 98%
86. Spbio_002915
87. 4-[l,l'biphenyl]ylacetic Acid
88. Bpbio1_000778
89. Chembl413965
90. Felbinac (jp17/usan/inn)
91. Zinc2318
92. Felbinac [ep Monograph]
93. Dtxsid0045389
94. 1,1'-biphenyl-4-ylacetic Acid
95. Hfn-310
96. Bdbm223312
97. Hms1570d08
98. Hms2097d08
99. Hms3714d08
100. Pharmakon1600-01506160
101. Bcp18699
102. Cs-d1194
103. Hy-b0641
104. Nsc16284
105. Tox21_110549
106. Ar1730
107. Nsc760372
108. S3685
109. Stk387569
110. Akos000119696
111. Tox21_110549_1
112. [1,1'-biphenyl]-4-ylacetic Acid #
113. Ac-8104
114. As-2883
115. Ccg-213621
116. Cs-8026
117. Db07477
118. Nsc-760372
119. Ncgc00016660-02
120. Ncgc00016660-03
121. Ncgc00016660-04
122. Ncgc00016660-06
123. Db-022648
124. Ab00384278
125. Ft-0602170
126. Ft-0617678
127. 28b529
128. B-2700
129. D01675
130. Ab00384278_14
131. Sr-01000003008
132. Q3742067
133. Sr-01000003008-2
134. Brd-k91740057-001-16-4
135. F2191-0076
136. Felbinac, European Pharmacopoeia (ep) Reference Standard
| Molecular Weight | 212.24 g/mol |
|---|---|
| Molecular Formula | C14H12O2 |
| XLogP3 | 3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 3 |
| Exact Mass | 212.083729621 g/mol |
| Monoisotopic Mass | 212.083729621 g/mol |
| Topological Polar Surface Area | 37.3 Ų |
| Heavy Atom Count | 16 |
| Formal Charge | 0 |
| Complexity | 223 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
M02AA08
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
M - Musculo-skeletal system
M02 - Topical products for joint and muscular pain
M02A - Topical products for joint and muscular pain
M02AA - Antiinflammatory preparations, non-steroids for topical use
M02AA08 - Felbinac
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A 4-Biphenylacetic Acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 4-Biphenylacetic Acid, including repackagers and relabelers. The FDA regulates 4-Biphenylacetic Acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 4-Biphenylacetic Acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 4-Biphenylacetic Acid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 4-Biphenylacetic Acid supplier is an individual or a company that provides 4-Biphenylacetic Acid active pharmaceutical ingredient (API) or 4-Biphenylacetic Acid finished formulations upon request. The 4-Biphenylacetic Acid suppliers may include 4-Biphenylacetic Acid API manufacturers, exporters, distributors and traders.
click here to find a list of 4-Biphenylacetic Acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The 4-Biphenylacetic Acid Drug Master File in Japan (4-Biphenylacetic Acid JDMF) empowers 4-Biphenylacetic Acid API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the 4-Biphenylacetic Acid JDMF during the approval evaluation for pharmaceutical products. At the time of 4-Biphenylacetic Acid JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of 4-Biphenylacetic Acid suppliers with JDMF on PharmaCompass.
4-Biphenylacetic Acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 4-Biphenylacetic Acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 4-Biphenylacetic Acid GMP manufacturer or 4-Biphenylacetic Acid GMP API supplier for your needs.
A 4-Biphenylacetic Acid CoA (Certificate of Analysis) is a formal document that attests to 4-Biphenylacetic Acid's compliance with 4-Biphenylacetic Acid specifications and serves as a tool for batch-level quality control.
4-Biphenylacetic Acid CoA mostly includes findings from lab analyses of a specific batch. For each 4-Biphenylacetic Acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
4-Biphenylacetic Acid may be tested according to a variety of international standards, such as European Pharmacopoeia (4-Biphenylacetic Acid EP), 4-Biphenylacetic Acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (4-Biphenylacetic Acid USP).
LOOKING FOR A SUPPLIER?
